VCF Indel encoding question

darren.obbard

Junior Member

Join Date: Jan 2012
Posts: 5

VCF Indel encoding question

05-23-2013, 09:34 AM

Hi,

I'm having problems understanding a GATK output VCF. I have read the VCF standard, but I'm obviously missing something.

I /think/ I understand how SNPs and short indels are represented, but clearly I do not. Below is an excerpt that illustrates sites which I do not understand. I suspect it may be something to do with GATK quality filters that I'm not understanding...

The excerpt below was generated using

GATK -l INFO -I my.bam -R my.fa -T UnifiedGenotyper -S LENIENT -nt 8 --heterozygosity 0.1 -o test.vcf --genotype_likelihoods_model BOTH --min_base_quality_score 10 --output_mode EMIT_ALL_SITES -ploidy 2

Thanks!

Darren

-------------------------------------------------------

Code:

CH1	225	.	T	G	12.71	LowQual	AC=1;AF=0.500;AN=2;BaseQRankSum=1.978;DP=59;Dels=0.03;FS=0.000;HaplotypeScore=10.2840;MLEAC=1;MLEAF=0.500;MQ=70.25;MQ0=8;MQRankSum=-5.349;QD=0.22;ReadPosRankSum=-3.188	GT:AD:DP:GQ:PL	0/1:41,16:55:20:20,0,1435
CH1	226	.	T	.	121.53	.	AN=2;DP=59;MQ=70.25;MQ0=8	GT:DP	0/0:43
CH1	227	.	A	.	121.53	.	AN=2;DP=59;MQ=70.25;MQ0=8	GT:DP	0/0:43
CH1	228	.	T	.	121.53	.	AN=2;DP=59;MQ=70.25;MQ0=8	GT:DP	0/0:43
CH1	229	.	A	.	115.53	.	AN=2;DP=57;MQ=69.66;MQ0=8	GT:DP	0/0:38
CH1	230	.	C	.	115.53	.	AN=2;DP=57;MQ=69.66;MQ0=8	GT:DP	0/0:38
CH1	231	.	T	.	115.53	.	AN=2;DP=57;MQ=69.66;MQ0=8	GT:DP	0/0:36
CH1	232	.	G	.	115.53	.	AN=2;DP=57;MQ=69.66;MQ0=8	GT:DP	0/0:36
CH1	233	.	C	.	115.53	.	AN=2;DP=57;MQ=69.66;MQ0=8	GT:DP	0/0:37
CH1	234	.	A	.	139.53	.	AN=2;DP=70;MQ=59.20;MQ0=14	GT:DP	0/0:63
CH1	235	.	A	.	175.53	.	AN=2;DP=84;MQ=51.67;MQ0=15	GT:DP	0/0:79
CH1	236	.	A	.	175.53	.	AN=2;DP=84;MQ=51.67;MQ0=15	GT:DP	0/0:79
CH1	237	.	T	.	175.53	.	AN=2;DP=85;MQ=51.37;MQ0=16	GT:DP	0/0:80
CH1	238	.	A	.	175.53	.	AN=2;DP=102;MQ=46.90;MQ0=28	GT:DP	0/0:97
CH1	238	.	A	AGAAAGAAAGCTTGTA	83.73	.	AC=1;AF=0.500;AN=2;BaseQRankSum=6.172;DP=102;FS=0.000;MLEAC=1;MLEAF=0.500;MQ=46.90;MQ0=0;MQRankSum=-6.190;QD=0.05;ReadPosRankSum=-5.733	GT:AD:DP:GQ:PL	0/1:27,25:57:99:121,0,4853
CH1	239	.	A	.	175.53	.	AN=2;DP=102;MQ=46.90;MQ0=28	GT:DP	0/0:101
CH1	240	.	T	.	175.53	.	AN=2;DP=102;MQ=46.90;MQ0=28	GT:DP	0/0:98
CH1	241	.	A	.	169.53	.	AN=2;DP=108;MQ=44.14;MQ0=29	GT:DP	0/0:107
CH1	242	.	T	.	169.53	.	AN=2;DP=109;MQ=43.94;MQ0=29	GT:DP	0/0:103
CH1	242	.	T	.	118.27	.	AN=2;DP=109;MQ=43.94;MQ0=29	GT:AD:DP	0/0:27:55
CH1	243	.	C	.	172.53	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:DP	0/0:108
CH1	243	.	CTTTT	.	118.27	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:AD:DP	0/0:27:56
CH1	244	.	T	.	91.53	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:DP	0/0:61
CH1	245	.	T	.	91.53	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:DP	0/0:53
CH1	246	.	T	.	73.53	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:DP	0/0:41
CH1	247	.	T	.	91.53	.	AN=2;DP=110;MQ=43.76;MQ0=29	GT:DP	0/0:46
CH1	248	.	A	.	172.53	.	AN=2;DP=116;MQ=42.61;MQ0=31	GT:DP	0/0:100
CH1	249	.	A	.	172.53	.	AN=2;DP=116;MQ=42.61;MQ0=31	GT:DP	0/0:100
CH1	250	.	T	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:101
CH1	251	.	T	.	169.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:96
CH1	251	.	T	.	118.27	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:AD:DP	0/0:27:56
CH1	252	.	C	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:113
CH1	253	.	C	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:110
CH1	254	.	T	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:111
CH1	255	.	T	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:111
CH1	256	.	T	.	172.53	.	AN=2;DP=117;MQ=42.43;MQ0=32	GT:DP	0/0:111

Line 1 is a SNP
Lines 14 and 15 are an indel that I do understand
Lines 19 and 20 I do /not/ understand
Lines 21 and 22 I do /not/ understand
---------------------------------------------------

Tags: gatk, indel, vcf

Torst

Senior Member

Join Date: Apr 2008

Posts: 275
Share

Post
#2

06-06-2013, 12:38 AM

Darren, maybe you should re-post with the lines numbered. You can use the Unix "nl" command to do this.
Comment

Previous template Next

Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool

by SEQadmin2

CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.¹ But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

Despite this, “CRISPR helped turn genome editing from a specialized...
- Channel: Articles
07-31-2026, 11:01 AM
Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications

by SEQadmin2

Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

The systematic characterization of the human proteome has...
- Channel: Articles
07-20-2026, 11:48 AM
Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems

by SEQadmin2

Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...
- Channel: Articles
07-09-2026, 11:10 AM

Topics	Statistics	Last Post
New Genomic Method Uncovers Ancient Hominin DNA by SEQadmin2 Started by SEQadmin2, 07-31-2026, 02:55 AM	0 responses 20 views 0 reactions	Last Post by SEQadmin2 07-31-2026, 02:55 AM
Study Captures the First Moments of DNA Replication by SEQadmin2 Started by SEQadmin2, 07-24-2026, 12:17 PM	0 responses 16 views 0 reactions	Last Post by SEQadmin2 07-24-2026, 12:17 PM
Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2 Started by SEQadmin2, 07-23-2026, 11:41 AM	0 responses 16 views 0 reactions	Last Post by SEQadmin2 07-23-2026, 11:41 AM
Single-Cell Atlases Skew Toward European Ancestry, Analysis Finds by SEQadmin2 Started by SEQadmin2, 07-20-2026, 11:10 AM	0 responses 26 views 0 reactions	Last Post by SEQadmin2 07-20-2026, 11:10 AM

Unconfigured Ad

VCF Indel encoding question

Comment

Latest Articles

ad_right_rmr

News